Combination therapy with oncolytic viruses and immune checkpoint inhibitors-Reference-Cited by-同舟云学术

Combination therapy with oncolytic viruses and immune checkpoint inhibitors

Published:2020-02-23 Issue:6 Volume:20 Page:635-652
ISSN:1471-2598
Container-title:Expert Opinion on Biological Therapy
language:en
Short-container-title:Expert Opinion on Biological Therapy

Author:

Chiu Matthew¹²,Armstrong Edward John Lloyd¹²,Jennings Vicki¹,Foo Shane¹,Crespo-Rodriguez Eva¹,Bozhanova Galabina¹,Patin Emmanuel Christian¹,McLaughlin Martin¹,Mansfield David¹,Baker Gabriella¹,Grove Lorna¹,Pedersen Malin¹,Kyula Joan¹,Roulstone Victoria¹,Wilkins Anna³,McDonald Fiona²,Harrington Kevin¹²,Melcher Alan¹²

Affiliation:

1. Division of Radiotherapy and Imaging, The Institute of Cancer Research, London, UK

2. The Royal Marsden NHS Foundation Trust, London, UK

3. Tumour Cell Biology Laboratory, The Francis Crick Institute, London, UK

Publisher

Informa UK Limited

Subject

Clinical Biochemistry,Drug Discovery,Pharmacology

Link

https://www.tandfonline.com/doi/pdf/10.1080/14712598.2020.1729351

Reference155 articles.

1. Cancer Immunotherapy: Historical Perspective of a Clinical Revolution and Emerging Preclinical Animal Models